Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Completed NCT04535882

Effectiveness of Serum Leucine-rich Alpha-2 Glycoprotein Levels on IBD

Conditions: LRG Levels

Sex: All

Healthy volunteers: No

Enrollment: 338

Sponsor: Showa Inan General Hospital

Location: Showa Inan General Hospital Komagane Nagano

Summary

We attempt to examine the association between serum leucine-rich alpha-2 glycoprotein (LRG) levels and endoscopic activity in patients with possible ulcerative colitis (UC) or Crohn's disease (CD) to determine whether LRG was a predicting marker for UC or CD.

Eligibility Criteria

Inclusion Criteria: * Patients whom possible UC or Crohn disease was suspected Exclusion Criteria: * other autoimmune diseases * acute or chronic renal failure * chronic heart diseases * liver cirrhosis * cancer * acute or chronic infections * ischemic colitis * infectious colitis

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT04535882). StuddyBuddy aggregates publicly available trial information.